|84.68||-0.2000||-0.24%||Vol 479.69K||1Y Perf 7.65%|
|Jun 27th, 2022 16:00 DELAYED|
|- -||- -%|
|Target Price||93.00||Analyst Rating||Strong Buy 1.00|
|Potential %||9.83||Finscreener Ranking||★★★ 49.66|
|Insiders Trans % 3/6/12 mo.||-/-/-||Value Ranking||★★+ 50.06|
|Insiders Value % 3/6/12 mo.||-/-/-||Growth Ranking||★★★+ 54.92|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-||Income Ranking||★★★+ 49.38|
|Price Range Ratio 52W %||82.38||Earnings Rating||Sell|
|Market Cap||10.40B||Earnings Date||3rd Aug 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||3rd Aug 2022|
|Estimated EPS Next Report||1.13|
|EPS Growth Next 5 Years %||10.00|
|Avg. Weekly Volume||752.83K|
|Avg. Monthly Volume||711.42K|
|Avg. Quarterly Volume||673.51K|
Amdocs Limited (NASDAQ: DOX) stock closed at 84.68 per share at the end of the most recent trading day (a -0.24% change compared to the prior day closing price) with a volume of 479.69K shares and market capitalization of 10.40B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Software industry, Technology sector and employs 26000 people. Amdocs Limited CEO is Shuky Sheffer.
The one-year performance of Amdocs Limited stock is 7.65%, while year-to-date (YTD) performance is 13.15%. DOX stock has a five-year performance of 31.39%. Its 52-week range is between 68.33 and 88.176, which gives DOX stock a 52-week price range ratio of 82.38%
Amdocs Limited currently has a PE ratio of 19.00, a price-to-book (PB) ratio of 2.93, a price-to-sale (PS) ratio of 2.36, a price to cashflow ratio of 13.90, a PEG ratio of 2.32, a ROA of 8.67%, a ROC of 12.69% and a ROE of 15.93%. The company’s profit margin is 12.84%, its EBITDA margin is 19.60%, and its revenue ttm is $4.40 Billion , which makes it $35.85 revenue per share.
Of the last four earnings reports from Amdocs Limited, there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $1.13 for the next earnings report. Amdocs Limited’s next earnings report date is 03rd Aug 2022.
The consensus rating of Wall Street analysts for Amdocs Limited is Strong Buy (1), with a target price of $93, which is +9.83% compared to the current price. The earnings rating for Amdocs Limited stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Amdocs Limited has a dividend yield of 1.87% with a dividend per share of $1.58 and a payout ratio of 26.00%.
Amdocs Limited has a Buy technical analysis rating based on Technical Indicators (ADX : 16.71, ATR14 : 2.11, CCI20 : 18.13, Chaikin Money Flow : -0.03, MACD : -0.61, Money Flow Index : 39.55, ROC : -1.76, RSI : 58.62, STOCH (14,3) : 77.01, STOCH RSI : 1.00, UO : 57.89, Williams %R : -22.99), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Amdocs Limited in the last 12-months were:
Fri, 13 May 2022 04:05 GMT Analysts Conflicted on These Technology Names: Amdocs (DOX), Spire Global (SPIR) and IsoPlexis (ISO)- TipRanks. All rights reserved.
Fri, 04 Feb 2022 01:15 GMT Amdocs (DOX) Gets a Hold Rating from Barclays- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro. Your capital is at risk.
This could take some time, please wait.